Higher doses of aspirin were associated with greater bleeding risks but not better ischemia outcomes in a study that followed 2,851 people after percutaneous coronary intervention for ST-segment elevation myocardial infarction. The study in the Journal of the American College of Cardiology: Cardiovascular Interventions examined three years of data from the HORIZONS-AMI trial.
Study: Less is better when it comes to aspirin after heart procedure
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||